The clinical recognition of acute lung disease caused by electronic cigarette (e-cigarette) usage has continued to grow. The identified pulmonary pathologies each include some degree of injury and/or inflammation. Electronic cigarettes contain chemicals that hold potential for acute pulmonary toxicity, including, but not limited to, nicotine, volatile organic compounds, and aldehydes. However, the development of chronic pulmonary diseases with more insidious symptoms has gained more recognition. Some chronic pulmonary diseases, such as sarcoidosis, have not yet been causally linked to electronic cigarette use. We present a case of a patient who developed sarcoidosis after using electronic cigarettes, discussing clinical outcomes and management of both the patient's electronic cigarette addiction and sarcoidosis development.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929206 | PMC |
http://dx.doi.org/10.14740/jmc3887 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!